Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To establish the safety profile of HuMax-CD38 when given as monotherapy in patients with multiple myeloma relapsed or refractory to at least 2 different cytoreductive therapies and without further established treatment options.
Critère d'inclusion
- Multiple myeloma